E70.338 ICD-10-CM Code: Other albinism with hematologic abnormality
E70.338 is not a CMS-HCC payment code. MEAT criteria · RAF Calculator · HCC coding software
HCC Buddy Code Card
Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.
FY 2026 Apr update / Endocrine, nutritional and metabolic diseases (E00-E89) / Metabolic disorders (E70-E88)
E70.338
Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidanceOther albinism with hematologic abnormality
A rare condition where abnormal skin and hair pigmentation (albinism) occurs alongside blood cell disorders, excluding Chediak-Higashi syndrome.

Buddy Insight
Other albinism with hematologic abnormality captures rare genetic conditions combining pigmentation defects with blood cell disorders that do not meet criteria for Chediak-Higashi syndrome or Hermansky-Pudlak syndrome.
CMS-HCC V28
N/A—
Not mapped
CMS-HCC V24
HistoricalHistorical
Not used for CY2026 payment
ACA/HHS
N/A—
Not mapped
ESRD/PACE
N/A—
Not mapped
RXHCC
MappedHCC 43
Code-level coefficient reference
Code Book Path
Inclusion Terms
OfficialICD-10-CM does not list inclusion terms for E70.338 in this effective period.
Excludes 2
OfficialICD-10-CM does not list Excludes 2 notes for E70.338 in this effective period.
Related Child Codes
Includes
OfficialICD-10-CM does not list Includes notes for E70.338 in this effective period.
Excludes 1
OfficialICD-10-CM does not list Excludes 1 notes for E70.338 in this effective period.
Code First
OfficialICD-10-CM does not list Code First sequencing instructions for E70.338 in this effective period.
Use Additional
OfficialICD-10-CM does not list Use Additional Code instructions for E70.338 in this effective period.
Code Also
OfficialICD-10-CM does not list Code Also instructions for E70.338 in this effective period.
Buddy Documentation Tip
MEAT Support
Audit Caution
Common Mistakes
Current with CMS: FY2026 ICD-10-CM Apr 1 update (effective Apr 1 – Sep 30, 2026) · CMS-HCC V28, 100% phased in for payment year 2026. FY2027 code set already staged for October 1, 2026. How HCC Buddy stays current →
Is E70.338 an HCC code?
E70.338 is not in the CMS-HCC V28 or V24 community payment model. E70.338 has a separate mapping under the CMS-HCC ESRD model (HCC 23 (Other Significant Endocrine and Metabolic Disorders)) and the Part D RxHCC model (HCC 43 (Pituitary, Adrenal Gland, and Other Endocrine and Metabolic Disorders)); the applicable result needs member context. E70.338 also appears in the HHS-HCC commercial risk model (HCC 028 (HHS-HCC 028 child, RAF varies by metal level)), where the result depends on member context and is not a Medicare Advantage payment mapping.
- Code
- E70.338
- Description
- Other albinism with hematologic abnormality
- HCC (V28)
- No CMS-HCC V28 mapping
- RAF reference coefficient
- —
- Billable
- Yes
- Payment year
- 2026
HCC Category Mapping
These are source-labeled model coefficients, not member totals. A category may still be removed by hierarchy or model cleanup rules. Weights are not directly comparable across models: CMS-HCC V28 and V24 use Community, Non-Dual, Aged; ESRD uses the dialysis continuing-enrollee model; RxHCC is the Part D continuing-enrollee, non-low-income, aged weight (a larger scale than CMS-HCC). ACA/HHS has no single weight — it varies by metal level. Actual per-patient RAF contribution depends on member context, hierarchy and cleanup rules, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains available for historical review.
Work E70.338 in the Code Book — tabular path, V28 RAF reference, and MEAT checklist →
MEAT Criteria for E70.338
For E70.338 to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically, it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed E70.338 during that encounter, not just copy-forwarded from a problem list.
Coder workflow notes
Get the V28 mapping + MEAT cheat sheet
One printable reference: check representative V28 mappings and the documentation reminders your note needs. Free, no card.
Free PDF. No card. Unsubscribe anytime.
What This Code Means
E70.338 is the ICD-10-CM diagnosis code for other albinism with hematologic abnormality. A rare condition where abnormal skin and hair pigmentation (albinism) occurs alongside blood cell disorders, excluding Chediak-Higashi syndrome. E70.338 sits in the ICD-10-CM chapter for endocrine, nutritional and metabolic diseases (e00-e89), within the section covering metabolic disorders (e70-e88).
E70.338 has no mapping under the CMS-HCC V28 or V24 community payment models. E70.338 has a separate mapping under the CMS-HCC ESRD model (HCC 23 (Other Significant Endocrine and Metabolic Disorders)) and the Part D RxHCC model (HCC 43 (Pituitary, Adrenal Gland, and Other Endocrine and Metabolic Disorders)); the applicable result needs member context. E70.338 also appears in the HHS-HCC commercial risk model (HCC 028 (HHS-HCC 028 child, RAF varies by metal level)), where the result depends on member context and is not a Medicare Advantage payment mapping. Do not assign V28 risk adjustment value from this page; verify the applicable model and payment year before using this code for risk adjustment.
Use this code only when albinism with hematologic abnormality is documented but is not Chediak-Higashi syndrome.
HCC Buddy maintains structured V28 and V24 mapping, source-labeled coefficient references, and MEAT documentation criteria for E70.338 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Use this code only when albinism with hematologic abnormality is documented but is not Chediak-Higashi syndrome
- •Ensure documentation specifies the type of hematologic abnormality present to support medical necessity
Clinical Significance
Other albinism with hematologic abnormality captures rare genetic conditions combining pigmentation defects with blood cell disorders that do not meet criteria for Chediak-Higashi syndrome or Hermansky-Pudlak syndrome. These may include Griscelli syndrome or other rare melanocyte and platelet granule disorders, each carrying distinct clinical implications for infection risk, bleeding, and organ-specific complications.
Documentation Requirements
- ✓Documentation should specify the exact condition diagnosed, supporting genetic test results, characterization of both the pigmentation defect and the hematologic abnormality (type, severity, clinical impact), and any organ complications.
- ✓The provider should clearly document why this does not qualify as Chediak-Higashi or Hermansky-Pudlak syndrome.
- ✓Treatment regimen and monitoring plan should be detailed.
Commonly Confused Codes
- •E70.330 (Chediak-Higashi syndrome) and E70.331 (Hermansky-Pudlak syndrome) are specific named syndromes that should be used when confirmed.
- •E70.339 (Albinism with hematologic abnormality, unspecified) is for cases where the specific type cannot be determined.
- •E70.320-E70.329 (Oculocutaneous albinism) does not include hematologic components.

